IL102919A0IL102919AIL10291992AIL102919A0IL 102919 A0IL102919 A0IL 102919A0IL 102919 AIL102919 AIL 102919AIL 10291992 AIL10291992 AIL 10291992AIL 102919 A0IL102919 A0IL 102919A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
xanthine derivatives
containing xanthine
derivatives
Prior art date
Application number
IL102919A
Original Assignee
Hoechst Roussel Pharma
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/131,785external-prioritypatent/US4965271A/en
Application filed by Hoechst Roussel Pharma, Univ VirginiafiledCriticalHoechst Roussel Pharma
Priority to IL102919ApriorityCriticalpatent/IL102919A0/en
Publication of IL102919A0publicationCriticalpatent/IL102919A0/en
Pharmaceutical formulations containing 1,3-disubstituted-7- (oxohydrocarbyl) xanthine derivatives for inhibiting the activity of leukocyte- derived cytokines